Loading clinical trials...
Loading clinical trials...
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions
Interventions
Nintedanib
Locations
173
United States
Jasper Summit Research, LLC
Jasper, Alabama, United States
Pulmonary Associates
Phoenix, Arizona, United States
University of California
Los Angeles, California, United States
University of California
San Francisco, California, United States
Sansum Clinic
Santa Barbara, California, United States
Stanford University Medical Center
Stanford, California, United States
Start Date
June 6, 2012
Primary Completion Date
July 5, 2017
Completion Date
February 1, 2021
Last Updated
March 25, 2022
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT07407543
NCT05989698
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions